nach oben

Erschienen in:

01.10.2013

Validation of a new quality of life scale related to multiple sclerosis and relapses

verfasst von: Antoine Baroin, Gilles Chopard, Gaye Siliman, Clément Michoudet, Aurore Vivot, Chrystelle Vidal, Hassna Mokadym, Annick Lavier, Ėric Berger, Lucien Rumbach, Nathalie Rude

Erschienen in: Quality of Life Research | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Multiple sclerosis (MS) has a significant impact on all aspects of patient quality of life (QoL). Furthermore, the fear of relapses and the feelings of patients during relapses must be taken into account in care. The objective of this work was to validate the PERSEPP scale (“PERception de la Sclérose En Plaques et de ses Poussées”), a new QoL evaluation scale for relapsing–remitting forms of MS.

Methods

Relapsing–remitting patients were included in a multicenter study. Various validation criteria of this scale were analyzed: acceptability, construct validity (internal and external validity), and reliability (internal consistency and reproducibility test–retest). Responsiveness will be studied in order to complete the validation process.

Results

The responses of 305 MS patients were analyzed. The process of reducing the items led us to retain 66 items of a total of 112 items. The 66-item PERSEPP scale (final version) was well accepted. Five dimensions (33 items) make up the scale: social support (α = 0.81), relationship difficulties (α = 0.71), fatigue (α = 0.74), state of mind and associated sleep disorders (α = 0.78), and time perspective (α = 0.75). Three additional modules (33 items) explore coping (α = 0.60), symptoms (α = 0.89), and treatment (α = 0.92). Test–retest reliability, measured by the intraclass correlation coefficient (ICC), was acceptable (0.72 < ICC < 0.92).

Conclusions

The PERSEPP scale has been validated and could be used in clinical trials and in daily practice. Additional studies will then complete the validation process.

Nur mit Berechtigung zugänglich

Siepman, T. A., Janssens, A. C., de Koning, I., Polman, C. H., Boringa, J. B., & Hintzen, R. Q. (2008). The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. Journal of Neurology, 255(6), 910–916.PubMedCrossRef

Penner, I. K., Bechtel, N., Raselli, C., Stöcklin, M., Opwis, K., Kappos, L., et al. (2007). Fatigue in multiple sclerosis: Relation to depression, physical impairment, personality and action control. Multiple Sclerosis, 13(9), 1161–1167.PubMedCrossRef

Solari, A. (2005). Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health and Quality of Life Outcomes, 3, 16.PubMedCrossRef

Clavelou, P., Auclair, C., Taithe, F., & Gerbaud, L. (2009). Quality of life in multiple sclerosis: Theoretical and practical aspects. Revue Neurologique, 165(2), F115–F124.PubMed

Riazi, A., Porter, B., Chataway, J., Thompson, A. J., & Hobart, J. C. (2011). A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: The Multiple Sclerosis Relapse Management Scale (MSRMS). Health and Quality of Life Outcomes, 9, 80.PubMedCrossRef

Vernay, D., Gerbaud, L., Biolay, S., Coste, J., Debourse, J., Aufauvre, D., et al. (2000). Quality of life and multiple sclerosis: Validation of the French version of the self-questionnaire (SEP-59). Revue Neurologique, 156(3), 247–263.PubMed

Baumstarck-Barrau, K., Pelletier, J., Simeoni, M.-C., Auquier, P., & the MusiQol Study Group. (2011). French validation of the Multiple Sclerosis International Quality of Life Questionnaire. Revista de Neurologia, 167(6–7), 511–521.CrossRef

McKenna, S. P., Doward, L. C., Twiss, J., Hagell, P., Oprandi, N. C., Fisk, J., et al. (2010). International development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS). Value Health, 13(8), 946–951.PubMedCrossRef

Hirst, C., Ingram, G., Pearson, O., Pickersgill, T., Scolding, N., & Robertson, N. (2008). Contribution of relapses to disability in multiple sclerosis. Journal of Neurology, 255(2), 280–287.PubMedCrossRef

10.

Ozakbas, S., Cagiran, I., Ormeci, B., & Idiman, E. (2004). Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Journal of the Neurological Sciences, 218(1–2), 3–7.PubMedCrossRef

11.

Halper, J. (2007). The psychosocial effect of multiple sclerosis: The impact of relapses. Journal of the Neurological Sciences, 256(1), S34–S38.PubMedCrossRef

12.

Kalb, R. (2007). The emotional and psychological impact of multiple sclerosis relapses. Journal of the Neurological Sciences, 256(1), S29–S33.PubMedCrossRef

13.

Baroin, A., Chopard, G., Mokadym, H., Lavier, A., Berger, E., Rumbach, L., et al. (2010). Establishing a quality of life scale related to relapses in multiple sclerosis. 62nd annual meeting of American Academy of Neurology, Toronto. Neurology, 74(2), A160.

14.

Baroin, A., Mokadym, H., Chopard, G., Lavier, A., Berger, E., Rumbach, L., et al. (2012). Establishing an evaluation scale for the perception of quality of life related to relapsing-remitting forms of multiple sclerosis and feasibility study. International Journal of Neuroscience, 122(1), 9–16.PubMedCrossRef

15.

Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452.PubMedCrossRef

16.

Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., et al. (1998). Cross-validation of item selection and scoring for the SF-12 health survey in Nine Countries: Results from the IQOLA project. Journal of Clinical Epidemiology, 51(11), 1171–1178.PubMedCrossRef

17.

Radat, F., Lafittau, M., Ouallet, J. C., Brochet, B., & Jouvent, R. (2007). Validation of EHD self questionnaire in multiple sclerosis. Encephale, 33(1), 49–57.PubMedCrossRef

18.

Simeoni, M.-C., Auquier, P., Fernandez, O., Flachenecker, P., Stecchi, S., Constantinescu, C. S., et al. (2008). Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis, 14(2), 219–230.PubMedCrossRef

19.

Falissard, B. (2001). Mesurer la subjectivité en santé. Perspective méthodologique et statistique (p. 211). Paris: Masson.

20.

Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory. New York: McGraw-Hill.

21.

Sébille, V., Hardouin, J.-B., Le Néel, T., Kubis, G., Boyer, F., Guillemin, F., et al. (2010). Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients—a simulation study. BMC Medical Research Methodology, 10, 24.PubMedCrossRef

22.

Prieto, L., Alonso, J., & Lamarca, R. (2003). Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health and Quality of Life Outcomes, 1, 27.PubMedCrossRef

23.

Penta, M., Arnould, C., & Decruynaere, C. (2005). Développer et interpréter une échelle de mesure. Applications du modèle de Rasch (p. 186). Sprimont: Mardaga.

24.

Ramp, M., Khan, F., Misajon, R. A., & Pallant, J. F. (2009). Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29). Health and Quality of Life Outcomes, 7, 58.PubMedCrossRef

25.

Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef

26.

Andrich, D., Sheridan, B. E., & Luo G. (2010). RUMM2030 (Rasch Unidimensional Measurement Model version 5.1) [Computer software]. Perth, Western Australia: RUMM Laboratory.

27.

Rummel, R. J. (1970). Applied factor analysis. Evanston, IL: Northwestern University Press.

28.

Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105.PubMedCrossRef

29.

Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86(2), 420–428.PubMedCrossRef

30.

Béthoux, F. (2006). Fatigue and multiple sclerosis. Annales de Réadaptation et de Médecine Physique, 49(6), 265–271.PubMedCrossRef

31.

Préau, M., Apostolidis, T., François, C., Raffi, F., & Spire, B. (2007). Time perspective and quality of life among HIV-infected patients in the context of HAART. AIDS Care, 19(4), 449–458.PubMedCrossRef

32.

Zimbardo, P. G., & Boyd, J. N. (1999). Putting time in perspective: A valid, reliable individual-differences metric. Journal of Personality and Social Psychology, 77, 1271–1288.CrossRef

33.

Montel, S. R., & Bungener, C. (2007). Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis. Multiple Sclerosis, 13(3), 393–401.PubMedCrossRef

34.

Moreau, T., Schmidt, N., Joyeux, O., Bungener, C., & Souvignet, V. (2009). Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatment. European Neurology, 62(2), 79–85.PubMedCrossRef

35.

Doward, L. C., McKenna, S. P., Meads, D. M., Twiss, J., & Eckert, B. J. (2009). The development of patient-reported outcome indices for multiple sclerosis (PRIMUS). Multiple Sclerosis, 15(9), 1092–1102.PubMedCrossRef

36.

Twiss, J., Doward, L. C., McKenna, S. P., & Eckert, B. (2010). Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS). Health and Quality of Life Outcomes, 8, 117.PubMedCrossRef

37.

Buljevac, D., Hop, W. C. J., Reedeker, W., Janssens, A. C. J. W., van der Meché, F. G. A., van Doorn, P. A., et al. (2003). Self reported stressful life events and exacerbations in multiple sclerosis: Prospective study. BMJ, 327(7416), 646.PubMedCrossRef

Titel: Validation of a new quality of life scale related to multiple sclerosis and relapses
verfasst von: Antoine Baroin
Gilles Chopard
Gaye Siliman
Clément Michoudet
Aurore Vivot
Chrystelle Vidal
Hassna Mokadym
Annick Lavier
Ėric Berger
Lucien Rumbach
Nathalie Rude
Publikationsdatum: 01.10.2013
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 8/2013
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-012-0334-0

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2013

On “A new indicator for the measurement of change with ordinal scores”

A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems

Health-related quality of life improvement via telemedicine for epilepsy: printed versus SMS-based education intervention

Family sense of coherence and quality of life

Condition-specific quality of life questionnaires for caregivers of children with pediatric conditions: a systematic review

Well-being in mothers of children with congenital heart defects: a 3-year follow-up